Display Title NAMS 2018 Weight 0 Tags NAMS 2018 Content TX-001HR is Associated with a Clinically Meaningful Effect on Severity of Moderate to Severe Vasomotor Symptoms in the REPLENISHTrial 312.7 KB 17β-Estradiol/Progesterone in a Single, Oral, Softgel Capsule (TX-001HR) Significantly Increased the Number of VMS Symptom-free Days in the REPLENISH Trial 252.7 KB Correlations of Serum Estradiol and Estrone Concentrations with Menopausal Outcomes and Bleeding 248.7 KB Systemic Estradiol Levels with Low-Dose Vaginal Estrogens May Differ by Dose and by Product 310.4 KB Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Metabolic Parameters and Cardiovascular Outcomes in Menopausal Women of the REPLENISH Trial 251.7 KB Effects of Single-Capsule 17β-Estradiol/Progesterone (TX-001HR) on Weight and Blood Pressure in Postmenopausal Women of the REPLENISH Trial 271.3 KB Categories Publications
